The developmental transcription factor GATA4 is overexpressed in pancreatic ductal adenocarcinoma

Matthew S. Karafin, Christopher T. Cummings, Baojin Fu, Christine A. Iacobuzio-Donahue

Research output: Contribution to journalArticle

Abstract

GATA4 is a transcription factor that plays a role in regulating the normal development of many mesoderm and endoderm derived tissues, including the pancreas. Silencing of GATA4 mRNA expression by promoter methylation has been implicated in carcinogenesis of the ovary, lung and colorectum. By contrast, GATA4 mRNA expression is upregulated in pancreatic cancer cell lines and tissues. To further clarify the relationship of GATA4 to pancreatic cancer, we immunolabeled 90 samples of pancreatic ductal adenocarcinoma using a GATA4 specific monoclonal antibody. Both the intensity and percent of labeling was recorded for each carcinoma and correlated to the clinicoμpathologic features available for each patient. Samples of normal adult (n=26) and fetal pancreatic tissue (n=8) were also immunolabeled for comparison to expression patterns in pancreatic carcinoma tissues. Immunolabeling for GATA4 indicated robust nuclear expression in developing acini in fetal pancreatic tissues, consistent with the role of GATA4 in embryologic development, and in mature pancreatic acinar epithelium. Immunolabeling for GATA4 was also noted within normal duct epithelial cells, although it was always lesser in intensity than for acinar cell nuclei in the same section. Positive GATA4 immunolabeling was seen in 61/90 (68%) infiltrating pancreatic cancers of which 27/90 (30%) showed strong positive labeling. While there was no relationship among GATA4 and patient age, race or pathologic features, we did find a significant association among strong positive labeling and female gender (p=0.01). These findings support previous studies implicating GATA4 in pancreatic cancer and offer new avenues for investigation into this aggressive tumor type.

Original languageEnglish (US)
Pages (from-to)47-55
Number of pages9
JournalInternational Journal of Clinical and Experimental Pathology
Volume3
Issue number1
StatePublished - 2010

Fingerprint

GATA4 Transcription Factor
Pancreatic Neoplasms
Adenocarcinoma
Fetus
Messenger RNA
Endoderm
Acinar Cells
Mesoderm
Cell Nucleus
Methylation
Pancreas
Ovary
Carcinogenesis
Transcription Factors
Epithelium
Epithelial Cells
Monoclonal Antibodies
Carcinoma
Cell Line
Lung

Keywords

  • Development
  • Embryology
  • Pancreatic cancer
  • Transcription factor

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology

Cite this

The developmental transcription factor GATA4 is overexpressed in pancreatic ductal adenocarcinoma. / Karafin, Matthew S.; Cummings, Christopher T.; Fu, Baojin; Iacobuzio-Donahue, Christine A.

In: International Journal of Clinical and Experimental Pathology, Vol. 3, No. 1, 2010, p. 47-55.

Research output: Contribution to journalArticle

Karafin, Matthew S. ; Cummings, Christopher T. ; Fu, Baojin ; Iacobuzio-Donahue, Christine A. / The developmental transcription factor GATA4 is overexpressed in pancreatic ductal adenocarcinoma. In: International Journal of Clinical and Experimental Pathology. 2010 ; Vol. 3, No. 1. pp. 47-55.
@article{feeeefb4635c41cf8a0ae6eef679e144,
title = "The developmental transcription factor GATA4 is overexpressed in pancreatic ductal adenocarcinoma",
abstract = "GATA4 is a transcription factor that plays a role in regulating the normal development of many mesoderm and endoderm derived tissues, including the pancreas. Silencing of GATA4 mRNA expression by promoter methylation has been implicated in carcinogenesis of the ovary, lung and colorectum. By contrast, GATA4 mRNA expression is upregulated in pancreatic cancer cell lines and tissues. To further clarify the relationship of GATA4 to pancreatic cancer, we immunolabeled 90 samples of pancreatic ductal adenocarcinoma using a GATA4 specific monoclonal antibody. Both the intensity and percent of labeling was recorded for each carcinoma and correlated to the clinicoμpathologic features available for each patient. Samples of normal adult (n=26) and fetal pancreatic tissue (n=8) were also immunolabeled for comparison to expression patterns in pancreatic carcinoma tissues. Immunolabeling for GATA4 indicated robust nuclear expression in developing acini in fetal pancreatic tissues, consistent with the role of GATA4 in embryologic development, and in mature pancreatic acinar epithelium. Immunolabeling for GATA4 was also noted within normal duct epithelial cells, although it was always lesser in intensity than for acinar cell nuclei in the same section. Positive GATA4 immunolabeling was seen in 61/90 (68{\%}) infiltrating pancreatic cancers of which 27/90 (30{\%}) showed strong positive labeling. While there was no relationship among GATA4 and patient age, race or pathologic features, we did find a significant association among strong positive labeling and female gender (p=0.01). These findings support previous studies implicating GATA4 in pancreatic cancer and offer new avenues for investigation into this aggressive tumor type.",
keywords = "Development, Embryology, Pancreatic cancer, Transcription factor",
author = "Karafin, {Matthew S.} and Cummings, {Christopher T.} and Baojin Fu and Iacobuzio-Donahue, {Christine A.}",
year = "2010",
language = "English (US)",
volume = "3",
pages = "47--55",
journal = "International Journal of Clinical and Experimental Pathology",
issn = "1936-2625",
publisher = "e-Century Publishing Corporation",
number = "1",

}

TY - JOUR

T1 - The developmental transcription factor GATA4 is overexpressed in pancreatic ductal adenocarcinoma

AU - Karafin, Matthew S.

AU - Cummings, Christopher T.

AU - Fu, Baojin

AU - Iacobuzio-Donahue, Christine A.

PY - 2010

Y1 - 2010

N2 - GATA4 is a transcription factor that plays a role in regulating the normal development of many mesoderm and endoderm derived tissues, including the pancreas. Silencing of GATA4 mRNA expression by promoter methylation has been implicated in carcinogenesis of the ovary, lung and colorectum. By contrast, GATA4 mRNA expression is upregulated in pancreatic cancer cell lines and tissues. To further clarify the relationship of GATA4 to pancreatic cancer, we immunolabeled 90 samples of pancreatic ductal adenocarcinoma using a GATA4 specific monoclonal antibody. Both the intensity and percent of labeling was recorded for each carcinoma and correlated to the clinicoμpathologic features available for each patient. Samples of normal adult (n=26) and fetal pancreatic tissue (n=8) were also immunolabeled for comparison to expression patterns in pancreatic carcinoma tissues. Immunolabeling for GATA4 indicated robust nuclear expression in developing acini in fetal pancreatic tissues, consistent with the role of GATA4 in embryologic development, and in mature pancreatic acinar epithelium. Immunolabeling for GATA4 was also noted within normal duct epithelial cells, although it was always lesser in intensity than for acinar cell nuclei in the same section. Positive GATA4 immunolabeling was seen in 61/90 (68%) infiltrating pancreatic cancers of which 27/90 (30%) showed strong positive labeling. While there was no relationship among GATA4 and patient age, race or pathologic features, we did find a significant association among strong positive labeling and female gender (p=0.01). These findings support previous studies implicating GATA4 in pancreatic cancer and offer new avenues for investigation into this aggressive tumor type.

AB - GATA4 is a transcription factor that plays a role in regulating the normal development of many mesoderm and endoderm derived tissues, including the pancreas. Silencing of GATA4 mRNA expression by promoter methylation has been implicated in carcinogenesis of the ovary, lung and colorectum. By contrast, GATA4 mRNA expression is upregulated in pancreatic cancer cell lines and tissues. To further clarify the relationship of GATA4 to pancreatic cancer, we immunolabeled 90 samples of pancreatic ductal adenocarcinoma using a GATA4 specific monoclonal antibody. Both the intensity and percent of labeling was recorded for each carcinoma and correlated to the clinicoμpathologic features available for each patient. Samples of normal adult (n=26) and fetal pancreatic tissue (n=8) were also immunolabeled for comparison to expression patterns in pancreatic carcinoma tissues. Immunolabeling for GATA4 indicated robust nuclear expression in developing acini in fetal pancreatic tissues, consistent with the role of GATA4 in embryologic development, and in mature pancreatic acinar epithelium. Immunolabeling for GATA4 was also noted within normal duct epithelial cells, although it was always lesser in intensity than for acinar cell nuclei in the same section. Positive GATA4 immunolabeling was seen in 61/90 (68%) infiltrating pancreatic cancers of which 27/90 (30%) showed strong positive labeling. While there was no relationship among GATA4 and patient age, race or pathologic features, we did find a significant association among strong positive labeling and female gender (p=0.01). These findings support previous studies implicating GATA4 in pancreatic cancer and offer new avenues for investigation into this aggressive tumor type.

KW - Development

KW - Embryology

KW - Pancreatic cancer

KW - Transcription factor

UR - http://www.scopus.com/inward/record.url?scp=77449156435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77449156435&partnerID=8YFLogxK

M3 - Article

C2 - 19918328

AN - SCOPUS:77449156435

VL - 3

SP - 47

EP - 55

JO - International Journal of Clinical and Experimental Pathology

JF - International Journal of Clinical and Experimental Pathology

SN - 1936-2625

IS - 1

ER -